Skip to main content

Veronica Miller, adjunct professor and director of the Forum for Collaborative Research at UC Berkeley School of Public Health, has received the 2024 Distinguished Advocacy Service Award from the American Association of Liver Diseases (AASLD).

The AASLD, based in Alexandria, Virginia, is the “leading organization of scientists and health care professionals committed to preventing and curing liver disease.” Their Distinguished Advocacy Service Award recognizes service provided to the liver disease community “over an extended period that raises awareness or garners public and federal legislative support and promotes liver health and quality patient care.”

Miller is an expert in regulatory science and has published well over 100 peer-reviewed papers on HIV treatment as well as regulatory strategies for HIV, liver disease, and other rare diseases.

The Forum for Collaborative Research, which Miller directs, is located in Washington, D.C., and is UC Berkeley School of Public Health’s hub for regulatory science. It’s a public/private partnership that has addressed cutting edge regulatory science and policy issues for over 20 years. This involves multidisciplinary teams in public health, medicine, biology, statistics, computer science, and data/regulatory science from academia, industry, governments, and communities.


People of UCBPH found in this article include:

Veronica Miller honored for work on liver disease © 2025 by UC Berkeley School of Public Health is licensed under CC BY-NC-ND 4.0 Creative Commons Credit must be given to the creator Only noncommercial use is permitted No derivatives or adaptations are permitted
  • What is CC BY-NC-ND 4.0?

    CC BY-NC-ND 4.0

    Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

    You are free to:
    • Share — copy and redistribute the material in any medium or format
    • The licensor cannot revoke these freedoms as long as you follow the license terms.
    Under the following terms:
    • BY Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
    • NC NonCommercial — You may not use the material for commercial purposes.
    • ND NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
    • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
    Learn more: